Ovarian cancer and resistance to therapies: Clinical and laboratory perspectives

Keyphrases

• Adjuvant Therapy 33%
• Advanced Stage Disease 33%
• Chemotherapy 66%
• Debulking Surgery 33%
• Drug Resistance 33%
• Effective Strategies 33%
• Gynecologic Malignancies 33%
• Intensive Care Medicine 33%
• Malignancy 66%
• Malignant Cells 33%
• Optimal Response 33%
• Ovarian Cancer 100%
• Ovarian Cancer Patients 100%
• Patient Survival 66%
• Peer-reviewed Literature 33%
• Platinum Drugs 33%
• Platinum-based Chemotherapy 66%
• Recurrent Disease 66%
• Relapsed Patients 33%
• Resistance to Therapy 100%
• Surgical Options 33%
• Term Analysis 33%
• Therapeutic Potential 33%
• Therapeutic Response 33%

Medicine and Dentistry

• Adjuvant Therapy 16%
• Cancer 50%
• Cytoreductive Surgery 16%
• Debulking Surgery 16%
• Diseases 33%
• Drug Resistance 16%
• Intensive Care 16%
• Malignant Neoplasm 16%
• Ovarian Cancer 100%
• Recurrent Disease 33%
• Side Effect 16%
• Treatment Response 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 66%
• Diseases 33%
• Drug Resistance 16%
• Malignant Neoplasm 16%
• Ovary Cancer 100%
• Recurrent Disease 33%
• Side Effect 16%